| NCT ID | NCT04712591 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Miami |
| Condition | Traumatic Brain Injury |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2020-06-18 |
| Primary Completion | 2030-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2020-06-18 with a primary completion date of 2030-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research study to find out if clinically unconscious acute brain injury patients that show brain activation to music and language on electroencephalogram (EEG) (bedside test) have better outcomes and wake up in the future.
Eligibility Criteria
Inclusion Criteria: For ABI Participants * ABI adult (18 years and older) patients who are admitted to the intensive care unit * Unconscious with Glasgow Coma Scale (GCS) \<8 on presentation and unable to follow bedside commands. * A negative COVID-19 test on arrival For Healthy Volunteers: * 18 years and older Exclusion Criteria: For All Participants: * \<18 years of age * Pregnant woman * Patients with cardiac arrest on presentation
Contact & Investigator
Ayham Alkhachroum, MD
PRINCIPAL INVESTIGATOR
University of Miami
Frequently Asked Questions
Who can join the NCT04712591 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Traumatic Brain Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04712591 currently recruiting?
Yes, NCT04712591 is actively recruiting participants. Contact the research team at axa2610@med.miami.edu for enrollment information.
Where is the NCT04712591 trial being conducted?
This trial is being conducted at Miami, United States, New York, United States.
Who is sponsoring the NCT04712591 clinical trial?
NCT04712591 is sponsored by University of Miami. The principal investigator is Ayham Alkhachroum, MD at University of Miami. The trial plans to enroll 300 participants.